TK 210 ELISA offers a simple and cost-effective assay for monitoring of patients under treatment. Preliminary studies show that AroCell TK 210 ELISA can be used to predict outcome and monitor effectiveness of drug treatment DLBCL, the most common non-Hodgkin’s Lymphoma.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.